Sabby Management’s BIO-key International BKYI Stock Holding History

Sabby Management’s Portfolio BKYI Stock Details BKYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-243	Closed	-$105K	–	130
2022 Q1	$105K	Buy	243 +46	+23%	+$18.6K	0.02%	116
2021 Q4	$78K	Buy	197 +86	+77%	+$43.4K	0.01%	161
2021 Q3	$70K	Buy	111 +17	+18%	+$10K	0.01%	165
2021 Q2	$65K	Sell	94 -92	-49%	-$60.5K	0.01%	154
2021 Q1	$117K	Buy	+186	New	+$134K	0.02%	146
2020 Q4	–	Sell	-69	Closed	-$44K	–	115
2020 Q3	$44K	Buy	+69	New	+$65.2K	0.01%	127

Other funds holding BKYI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Sabby Management's BKYI Position: Q2 2022 in Review

Sabby Management sold out of BIO-key International (BKYI) in Q2 2022, closing a stake of 243 shares — an estimated $105K sold.

Sabby Management first reported a position in BKYI in Q3 2020 and held it in 6 quarters. The position peaked at $117K in Q1 2021. 8 funds tracked by Wall St. Rank hold BKYI as of Q2 2022.

Sabby Management reported no remaining BIO-key International position as of Q2 2022 after selling out during the quarter.
Sabby Management sold 243 BIO-key International shares in Q2 2022, an estimated $105K.
Sabby Management first reported a position in BIO-key International in Q3 2020 and held it in 6 quarters.
Sabby Management's BIO-key International position peaked at $117K in Q1 2021.
8 funds tracked by Wall St. Rank held BIO-key International as of Q2 2022.

Based on Sabby Management's 13F filing for Q2 2022, filed 15 Aug 2022.